IL166548A0 - Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide - Google Patents
Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amideInfo
- Publication number
- IL166548A0 IL166548A0 IL16654805A IL16654805A IL166548A0 IL 166548 A0 IL166548 A0 IL 166548A0 IL 16654805 A IL16654805 A IL 16654805A IL 16654805 A IL16654805 A IL 16654805A IL 166548 A0 IL166548 A0 IL 166548A0
- Authority
- IL
- Israel
- Prior art keywords
- octylü
- carbampyl
- acidä4
- fluorobenzyl
- quinoxaline
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- UPUZGXILYFKSGE-UHFFFAOYSA-N quinoxaline-2-carboxylic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CN=C21 UPUZGXILYFKSGE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40321602P | 2002-08-12 | 2002-08-12 | |
| PCT/IB2003/003464 WO2004014875A1 (en) | 2002-08-12 | 2003-07-31 | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166548A0 true IL166548A0 (en) | 2006-01-15 |
Family
ID=31715961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16654805A IL166548A0 (en) | 2002-08-12 | 2005-01-27 | Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20040072834A1 (de) |
| EP (1) | EP1539715A1 (de) |
| JP (1) | JP2005538130A (de) |
| AP (1) | AP2005003226A0 (de) |
| AR (1) | AR040839A1 (de) |
| AU (1) | AU2003250450A1 (de) |
| BR (1) | BR0313378A (de) |
| CA (1) | CA2494776A1 (de) |
| EC (1) | ECSP055588A (de) |
| GT (1) | GT200300169A (de) |
| IL (1) | IL166548A0 (de) |
| IS (1) | IS7674A (de) |
| MX (1) | MXPA05001781A (de) |
| NO (1) | NO20050540L (de) |
| OA (1) | OA12894A (de) |
| PA (1) | PA8580401A1 (de) |
| PE (1) | PE20040866A1 (de) |
| TN (1) | TNSN05035A1 (de) |
| TW (1) | TW200407316A (de) |
| UY (1) | UY27928A1 (de) |
| WO (1) | WO2004014875A1 (de) |
| ZA (1) | ZA200500768B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102822163B (zh) | 2009-12-23 | 2016-01-20 | 艾恩伍德医药品股份有限公司 | Crth2调节剂 |
| WO2012009137A1 (en) | 2010-07-12 | 2012-01-19 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| US20130259830A1 (en) | 2010-07-12 | 2013-10-03 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| CN102276539B (zh) * | 2011-06-29 | 2013-08-14 | 赵雪梅 | 一种具有抑菌作用的化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE640616A (de) * | 1962-12-19 | |||
| US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
| US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
| US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
| US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
| SK112899A3 (en) * | 1997-02-26 | 2001-05-10 | Pfizer | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| ATE337307T1 (de) * | 1998-02-05 | 2006-09-15 | Pfizer Prod Inc | Neue dihydroxyhexansäurederivate |
-
2003
- 2003-07-31 CA CA002494776A patent/CA2494776A1/en not_active Abandoned
- 2003-07-31 WO PCT/IB2003/003464 patent/WO2004014875A1/en not_active Ceased
- 2003-07-31 BR BR0313378-8A patent/BR0313378A/pt not_active Application Discontinuation
- 2003-07-31 AP AP2005003226A patent/AP2005003226A0/xx unknown
- 2003-07-31 JP JP2004527195A patent/JP2005538130A/ja active Pending
- 2003-07-31 MX MXPA05001781A patent/MXPA05001781A/es not_active Application Discontinuation
- 2003-07-31 AU AU2003250450A patent/AU2003250450A1/en not_active Abandoned
- 2003-07-31 EP EP03784383A patent/EP1539715A1/de not_active Withdrawn
- 2003-07-31 OA OA1200500028A patent/OA12894A/en unknown
- 2003-08-05 UY UY27928A patent/UY27928A1/es not_active Application Discontinuation
- 2003-08-06 GT GT200300169A patent/GT200300169A/es unknown
- 2003-08-06 TW TW092121503A patent/TW200407316A/zh unknown
- 2003-08-08 AR AR20030102881A patent/AR040839A1/es unknown
- 2003-08-08 PE PE2003000794A patent/PE20040866A1/es not_active Application Discontinuation
- 2003-08-08 US US10/637,475 patent/US20040072834A1/en not_active Abandoned
- 2003-08-12 PA PA20038580401A patent/PA8580401A1/es unknown
-
2005
- 2005-01-26 ZA ZA200500768A patent/ZA200500768B/xx unknown
- 2005-01-27 IS IS7674A patent/IS7674A/is unknown
- 2005-01-27 IL IL16654805A patent/IL166548A0/xx unknown
- 2005-01-31 NO NO20050540A patent/NO20050540L/no unknown
- 2005-02-03 EC EC2005005588A patent/ECSP055588A/es unknown
- 2005-02-11 TN TNP2005000035A patent/TNSN05035A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004014875A1 (en) | 2004-02-19 |
| EP1539715A1 (de) | 2005-06-15 |
| IS7674A (is) | 2005-01-27 |
| GT200300169A (es) | 2004-05-12 |
| AU2003250450A1 (en) | 2004-02-25 |
| UY27928A1 (es) | 2004-03-31 |
| BR0313378A (pt) | 2005-07-12 |
| TW200407316A (en) | 2004-05-16 |
| JP2005538130A (ja) | 2005-12-15 |
| US20040072834A1 (en) | 2004-04-15 |
| CA2494776A1 (en) | 2004-02-19 |
| PE20040866A1 (es) | 2004-11-26 |
| MXPA05001781A (es) | 2005-04-25 |
| AP2005003226A0 (en) | 2005-03-31 |
| OA12894A (en) | 2006-10-13 |
| TNSN05035A1 (fr) | 2007-05-14 |
| ECSP055588A (es) | 2005-04-18 |
| NO20050540L (no) | 2005-03-10 |
| ZA200500768B (en) | 2006-07-26 |
| AR040839A1 (es) | 2005-04-20 |
| PA8580401A1 (es) | 2004-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2389161B (en) | Composite wave ring spring | |
| AU2003282548A8 (en) | Nano-chem-fet based biosensors | |
| AU2003295539A8 (en) | Allele-targeted rna interference | |
| IL164597A0 (en) | Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses | |
| IL164703A0 (en) | ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof | |
| AU2003255831A1 (en) | Delayed-gelation solution | |
| ZA200304085B (en) | Set of elements for assembling structures. | |
| AU2003225095A1 (en) | Parallel sizing, dosing and transfer assembly and method of use | |
| ZA200501624B (en) | Flat lamp, production method thereof and application of same. | |
| AU2003298913A1 (en) | Treatment of inflammatory disorders with 2,3-benzodiazepines | |
| IL166450A0 (en) | Drug discovery method | |
| AU2003222120A1 (en) | Oxon process | |
| TWI367754B (en) | New carboxamide compound | |
| AU2003216848A1 (en) | Deracemisation of amines | |
| AP2005003226A0 (en) | Crystal forms of quinoxaline-2-carboxylic acid[4-carbamoyl-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide. | |
| AU2003206438A1 (en) | Assembly of structural elements, structural element and use of such an assembly | |
| AU2003287844A1 (en) | Novel crystalline forms of entacapone, and production thereof | |
| DE50308194D1 (en) | Polyamide | |
| GB2392746B (en) | Comparison of molecules using field points | |
| TWI318790B (en) | High-frequency substrate | |
| IL173447A0 (en) | Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same | |
| GB2389743B (en) | Networks | |
| EP1548152A4 (de) | Elektrodenherstellungsverfahren | |
| AU2003255307A1 (en) | Arylamides | |
| ZA200303039B (en) | Method of advertising. |